Nobel medicine prize goes to trio for optogenetics breakthrough
· Health · United States · Germany
The 2026 Nobel Prize in physiology or medicine was awarded to US psychiatrist and neurologist Karl Deisseroth and German scientists Peter Hegemann and Georg Nagel for pioneering work in optogenetics, which allows researchers to control nerve cells using light. The technique uses light-gated ion channels to stimulate neurones, potentially unlocking new treatments for brain and psychiatric disorders. The prize recognises discoveries that have become a foundational tool in neuroscience, letting scientists switch specific brain cells on and off with precision.
Why it matters:Optogenetics has transformed brain research and could lead to treatments for neurological and psychiatric conditions, benefiting patients worldwide.
Key points
- The prize went to Karl Deisseroth, Peter Hegemann and Georg Nagel.
- Optogenetics controls neurones by stimulating them with light.
- The method uses light-gated ion channels to switch brain cells on and off.
Sources (original reporting)
More stories from this day
- Nobel-winning optogenetics unlocks light-based control of brain cells
- New York declares measles disaster emergency as US outbreak spreads
- Siberia plague scare: lab worker dies, nearly 200 under observation
- Pennsylvania surpasses 1,000 measles cases, largest in decades
- Shionogi to buy US-based IntraBio for $2bn to expand rare disease drugs
- Trump approval falls to record 32% ahead of US midterms